Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Exploding Airbag Recalls Result in Landmark $200M Fine Against Takata November 4, 2015 Irvin Jackson Add Your Comments Federal regulators have imposed what they say is a historic fine against Takata, a Japanese parts manufacturer responsible for problems with airbags used in millions of vehicles, which are prone to overinflate and explode, often causing severe or fatal injuries for passengers. The National Highway Traffic Safety Administration (NHTSA) announced that a consent order (PDF) was filed against Takata Holdings on November 3, which could require the company to pay up to $200 million in fines; $70 million now and $130 million if the company fails to meet the obligations of the consent order. The fines and the order, which also includes requirements to speed up the pace of Takata airbag recall repairs, comes after about 100 injuries and at least seven deaths have been linked to defective airbag inflators used in vehicles sold by about a dozen different auto makers. Learn More About Airbag Recall Lawsuits Millions of Vehicles Were Recalled in 2014 Due to Exploding Airbags That Caused Injuries and Deaths. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Airbag Recall Lawsuits Millions of Vehicles Were Recalled in 2014 Due to Exploding Airbags That Caused Injuries and Deaths. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “For years, Takata has built and sold defective products, refused to acknowledge the defect, and failed to provide full information to NHTSA, its customers, or the public,” Transportation Secretary Anthony Foxx said in a press release. “The result of that delay and denial has harmed scores of consumers and caused the larges, most complex safety recall in history. Today’s actions represent aggressive use of NHTSA’s authority to clean up these problems and protect public safety.” The Takata airbag recalls date back to at least 2009, according to the NHTSA, and have affected 23 million inflators used in 19 million vehicles. The consent order includes an admission of guilt by Takata, which acknowledges that it knew about the defects but failed to warn the public or federal regulators in a timely manner. The company must phase out the manufacture and sale of airbag inflators that use phase-stabilized ammonium nitrate propellant, and also requires the company to recall any remaining airbags on the roads in the U.S. that use the propellant or show how and why they are safe. The company will also be under a five year oversight plan that will require an independent monitor to make sure that the company is living up to the obligations of the consent order. Failure to do so will activate the remaining $130 million of the penalties. The $70 million initial fine is to be paid immediately. “Today, we are holding Takata responsible for its failures, and we are taking strong action to protect the traveling public,” NHTSA Administrator Mark Rosekind said in the press release. “We are accelerating Takata recalls to get safe air bags into American vehicles more quickly, ensuring that consumers at the greatest risk are protected, and addressing the long-term risk of Takata’s use of a suspect propellant.” NHTSA Takes Control of Exploding Airbag Repairs In addition to the consent order, the NHTSA also announced a Coordinated Remedy order (PDF) for Takata and vehicle manufacturers. The order is designed to not only speed up the recalls, which have lagged due to a lack of parts, but to also make manufacturers and Takata prioritize the recalls so that the air bags most likely to explode are repaired first. The highest risk airbags are those that are operated in high humidity areas and are older. Vehicles with two airbags affected by the recalls are also given a priority. The NHTSA has given Takata and auto manufacturers until March 2016 to repair the highest risk airbags. They must have parts and plans to be able to repair all of the recalled Takata airbags by the end of 2019. At a public information meeting last month, the NHTSA reported that only 22.5% of recalled Takata airbags have been repaired. The replacements have been focused on areas of high humidity, where the ruptures are considered more likely. About 30% of vehicles in those regions have been repaired. Takata has ramped up production of replacement airbag inflators to 2.8 million units per month. However, most of those are being subcontracted to other parts suppliers. Takata Airbag Explosion Lawsuits The consent order does nothing to address the civil lawsuits Takata faces from an angry public and from people who were injured or lost loved ones due to the company’s exploding airbags. A growing number of Takata airbag lawsuits continue to be filed nationwide on behalf of individuals who suffered severe injuries from an exploding airbag. All involve similar allegations that design defects caused the airbags to overinflate and rupture. Since February 2015, all federal airbag lawsuits against Takata have been centraliszed before one judge for pretrial proceedings as part of an MDL, or multidistrict litigation. Complaints filed throughout the federal court system are transferred to U.S. District Judge Federico Moreno in the Southern District of Florida to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts. Given the lack of a Takata airbag settlement fund to attempt to resolve claims early in the process, injured individuals and families of those killed may face years of litigation before compensation is obtained. New Takata Airbag Problems May Loom While Takata has agreed to the fine for exploding airbags sold in recent years, the manufacturer appears to face a problem with some newer inflators. Honda announced earlier this week that it is recalling about 515 additional CR-V sport utility vehicles from the 2016 model year due to manufacturing problems with other Takata airbags. According to the NHTSA safety recall report (PDF), the airbag inflator in the driver frontal airbag “may have been improperly stamped and/or contains a defect in the material used to manufacture the airbag inflator’s metal housing” that could cause the airbags to explode. The airbags were manufactured at Takata’s Monclova, Mexico production plant, which discovered the problem during testing and notified the NHTSA on October 12. The cause of the problem is not yet known. Honda said it will begin notifying vehicle owners on December 4. However, it is believed that only about 30 of the affected vehicles were sold. Tags: Airbag Recall, Honda, Takata Image Credit: Image via <a href="http://www.shutterstock.com/gallery-320989p1.html?cr=00&pl=edit-00">360b</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a> More Takata Airbag Lawsuit Stories Ford Fined $165M Over Inaccurate Recall That Was Conducted Too Slowly for Customer Safety November 21, 2024 Volkswagen Airbag Recall Impacts Nearly 115,000 Beetles and Passats November 11, 2024 BMW Recall Issued for Nearly 400K Vehicles with Airbags That May Explode July 16, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Ford Fined $165M Over Inaccurate Recall That Was Conducted Too Slowly for Customer Safety November 21, 2024
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)